The Trump administration is seeking to restrict US investment in Chinese biotechnology companies, according to Bloomberg. The effort could complicate financial ties as US drugmakers increasingly turn to China for new medicines.
Article
GEOPOLITICS | US Seeks Restrictions on Investment in Chinese Biotech Firms
--・
Disclaimer: Includes third-party opinions. No advice. Binance AI may be used without guarantee. See T&Cs.